Reports › TXN › 10-Q FY2026

SEC filings, compared

What changed in Texas Instruments's 10-Q for the quarter ended June 30, 2026

Compared with the 10-Q for the quarter ended June 30, 2025. Part I, Item 2 and Part II, Item 1A analysed; every summary checked against the quoted filing text.

Registrant: TEXAS INSTRUMENTS INC · TXN
This filing: 0000097476-26-000152 ↗ · filed Jul 24, 2026
Compared with: 0000097476-25-000036 ↗ · filed Jul 29, 2025
Processed: Sep 20, 2026 UTC · parser-v5 · classify-v4 · select-v1

Research tool. Describes what filings say. Not investment advice. Verify independently. Read the cited paragraph before relying on it.

How a report is made

40 material changes among 63 changed paragraphs

15 shown by default across the three sections below; each section's "Show all" reaches the rest, in filing order.

Numbers from XBRL

Each figure is the one the filing itself tagged, taken from the filing that reported it. Not written by a model.

Concept	FY2026	FY2025	Change (our arithmetic)
Revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax	5,463,000,000USD · Apr 1, 2026 to Jun 30, 2026	4,448,000,000USD · Apr 1, 2025 to Jun 30, 2025	+1,015,000,000+22.8%
Net income or lossus-gaap:NetIncomeLoss	1,980,000,000USD · Apr 1, 2026 to Jun 30, 2026	1,295,000,000USD · Apr 1, 2025 to Jun 30, 2025	+685,000,000+52.9%
Cash and cash equivalentsus-gaap:CashAndCashEquivalentsAtCarryingValue	3,660,000,000USD · at Jun 30, 2026	3,044,000,000USD · at Jun 30, 2025	+616,000,000+20.2%
Net cash from operating activitiesus-gaap:NetCashProvidedByUsedInOperatingActivities	4,223,000,000USD · Jan 1, 2026 to Jun 30, 2026	2,709,000,000USD · Jan 1, 2025 to Jun 30, 2025	+1,514,000,000+55.9%

Values as tagged in the filing's inline XBRL, resolved by accession rather than by period matching. When a value is not tagged, we show that instead of estimating it. FY2026: 0000097476-26-000152 · FY2025: 0000097476-25-000036

What the company says for the first time

Paragraphs with no counterpart in the prior filing.

7 material additions

Part I, Item 2 · MD&A

7 of 7 shown · In filing order, too few to rank

01AddedPart I, Item 2 › Results of operations

Summary · quote-checked

Added disclosure that the LFAB facility is ramping production and will affect Embedded Processing manufacturing costs and operating profit allocation.

The new paragraph introduces a facility ramp, expected factory loading increases, and a stated effect on business-segment costs and operating profit, changing disclosed operating dependencies and outlook.

Filing text · FY2025 10-Q · filed Jul 29, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] ◦ Our LFAB facility, which primarily supports our Embedded Processing business, was purchased as an operating fab and is continuing to ramp production, so we expect factory loadings to increase over time. As LFAB ramps, we expect Embedded to carry manufacturing costs that disproportionately benefit Embedded Processing operating profit as compared to Analog.

Cite this change

"Our LFAB facility, which primarily supports our Embedded Processing business, was purchased as an operating fab and is continuing to ramp production, so we expect factory loadings to increase over time. As LFAB ramps, we expect Embedded to carry manufacturing costs that disproportionately benefit Embedded Processing operating profit as compared to Analog."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

02AddedPart I, Item 2 › Acquisition of Silicon Labs

Summary · quote-checked

Added disclosure of a definitive agreement to acquire Silicon Labs for approximately $7.5 billion, subject to regulatory approvals and debt financing.

The paragraph introduces a new acquisition, purchase obligation, financing dependency, and regulatory closing condition, materially changing disclosed commitments and transaction exposure.

Filing text · FY2025 10-Q · filed Jul 29, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] As announced on February 4, 2026, we have entered into a definitive agreement to acquire Silicon Labs for $231.00 per share in an all-cash transaction, representing a total enterprise value of approximately $7.5 billion. Under the terms of the agreement, Silicon Labs stockholders will receive $231.00 in cash for each share of Silicon Labs common stock they hold at the time of closing, which is expected in the first half of 2027, subject to receipt of regulatory approvals and other customary closing conditions. We expect to fund the transaction with a combination of cash on hand and debt financing.

Cite this change

"As announced on February 4, 2026, we have entered into a definitive agreement to acquire Silicon Labs for $231.00 per share in an all-cash transaction, representing a total enterprise value of approximately $7.5 billion. Under the terms of the agreement, Silicon Labs stockholders will receive $231.00 in cash for each share of Silicon Labs common stock they hold at the time of closing, which is expected in the first half of 2027, subject to receipt of regulatory approvals and other customary closing conditions. We expect to fund the transaction with a combination of cash on hand and debt financing."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

03AddedPart I, Item 2 › Acquisition of Silicon Labs

Summary · quote-checked

Added disclosure of a $5 billion delayed draw term loan facility supporting the Silicon Labs acquisition and related transaction expenses.

The paragraph introduces a new financing facility and potential borrowing obligation, while stating that no borrowings were outstanding as of June 30, 2026.

Filing text · FY2025 10-Q · filed Jul 29, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] In June 2026, we entered into a 364-day delayed draw term loan credit facility for borrowings up to $5 billion to support the Silicon Labs acquisition consideration and related transaction expenses. As of June 30, 2026, there were no outstanding borrowings on the delayed draw term loan credit facility.

Cite this change

"In June 2026, we entered into a 364-day delayed draw term loan credit facility for borrowings up to $5 billion to support the Silicon Labs acquisition consideration and related transaction expenses."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

04AddedPart I, Item 2 › Details of financial results - second quarter 2026 compared with second quarter 2025

Summary · quote-checked

Added disclosure of $17 million in acquisition charges tied to transaction-related costs for the planned acquisition of Silicon Labs.

The new paragraph discloses a specific expense and planned acquisition, introducing a transaction and financial obligation not previously disclosed.

Filing text · FY2025 10-Q · filed Jul 29, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] Acquisition charges were $17 million due to transaction-related costs associated with our planned acquisition of Silicon Labs.

Cite this change

"Acquisition charges were $17 million due to transaction-related costs associated with our planned acquisition of Silicon Labs."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

05AddedPart I, Item 2 › Second quarter 2026 segment results

Summary · quote-checked

A new note states that reported results include acquisition charges.

The added text identifies acquisition charges as included in the reported results, introducing a substantive expense component rather than merely updating formatting or dates.

Filing text · FY2025 10-Q · filed Jul 29, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] *Includes Acquisition charges

Cite this change

"*Includes Acquisition charges"

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

06AddedPart I, Item 2 › Details of financial results - first six months of 2026 compared with first six months of 2025

Summary · quote-checked

Added disclosure of $34 million in acquisition charges tied to the planned Silicon Labs acquisition.

The new paragraph discloses a transaction-related cost and identifies a specific planned acquisition, adding information about an obligation and corporate event.

Filing text · FY2025 10-Q · filed Jul 29, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] Acquisition charges were $34 million due to transaction-related costs associated with our planned acquisition of Silicon Labs.

Cite this change

"Acquisition charges were $34 million due to transaction-related costs associated with our planned acquisition of Silicon Labs."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

07AddedPart I, Item 2 › Year-to-date segment results

Summary · quote-checked

Added a disclosure that segment results include acquisition charges.

The new paragraph identifies acquisition charges within segment results, adding substantive information about an expense component rather than merely updating wording or formatting.

Filing text · FY2025 10-Q · filed Jul 29, 2025

No corresponding language in the FY2025 10-Q.

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] *Includes Acquisition charges

Cite this change

"*Includes Acquisition charges"

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

What the company no longer says

Paragraphs of the prior filing that this filing dropped. Only last year's text can show these.

3 material removals

Part I, Item 2 · MD&A

3 of 3 shown · In filing order, too few to rank

01RemovedPart I, Item 2 › Macroeconomic factors

Summary · quote-checked

The current filing removes disclosure about tariffs, geopolitics, supply-chain disruption, customer orders, semiconductor recovery, and customer inventory levels.

A substantive macroeconomic and operational disclosure was removed, including stated supply-chain effects, customer behavior, market recovery, and inventory conditions.

Filing text · FY2025 10-Q · filed Jul 29, 2025

[removed] We believe tariffs and geopolitics are disrupting and reshaping global supply chains and affecting customer order behavior. Our global manufacturing capabilities enable us to support our customers' needs. We also believe the semiconductor cycle recovery is continuing, while customer inventories remain at low levels.

Filing text · FY2026 10-Q · filed Jul 24, 2026

No corresponding language in the FY2026 10-Q.

Cite this change

"We believe tariffs and geopolitics are disrupting and reshaping global supply chains and affecting customer order behavior."

Texas Instruments, Form 10-Q for FY2025, Part I, Item 2, accession 0000097476-25-000036, filed 29 July 2025.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747625000036/txn-20250630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

02RemovedPart I, Item 2 › U.S. legislative update

Summary · quote-checked

Removed disclosure about the OBBBA’s tax-law changes and their expected effects on tax rates and tax-related cash payments.

The removed paragraph described enacted legislation, a new tax-law impact, expected changes to effective tax rates, and lower future tax-related cash payments; its substance is not merely recurring or presentational.

Filing text · FY2025 10-Q · filed Jul 29, 2025

[removed] On July 4, 2025, the U.S. government enacted the One Big Beautiful Bill Act (OBBBA). The OBBBA provides changes to U.S. federal tax law, including expensing of U.S. research expenditures and eligible capital expenditures, increasing the U.S. CHIPS and Science Act (CHIPS Act) investment tax credit (ITC) and changing other tax provisions. The new law did not impact our financial condition and results of operations during the second quarter. We are currently evaluating the impact of the legislation on future periods. Based on our initial assessment, the changes are expected to result in a higher effective tax rate in the third quarter and full year 2025. For 2026 and beyond, we expect the effective tax rate to be lower than it would have been under prior tax law. Additionally, we expect tax-related cash payments to be lower for the next several years as a result of the changes.

Filing text · FY2026 10-Q · filed Jul 24, 2026

No corresponding language in the FY2026 10-Q.

Cite this change

"On July 4, 2025, the U.S. government enacted the One Big Beautiful Bill Act (OBBBA). The OBBBA provides changes to U.S. federal tax law, including expensing of U.S. research expenditures and eligible capital expenditures, increasing the U.S. CHIPS and Science Act (CHIPS Act) investment tax credit (ITC) and changing other tax provisions."

Texas Instruments, Form 10-Q for FY2025, Part I, Item 2, accession 0000097476-25-000036, filed 29 July 2025.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747625000036/txn-20250630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

03RemovedPart I, Item 2 › Details of financial results - first six months of 2025 compared with first six months of 2024

Summary · quote-checked

The disclosure of a prior-period restructuring credit and its property-sale gain driver was removed.

The removed sentence describes a specific financial event and explains the driver of restructuring charges; its disappearance changes the disclosed results narrative beyond a period roll-forward.

Filing text · FY2025 10-Q · filed Jul 29, 2025

~~[removed] Restructuring charges/other in the year-ago period was a credit of $124 million primarily due to a gain on the sale of a property during 2024.~~

Filing text · FY2026 10-Q · filed Jul 24, 2026

No corresponding language in the FY2026 10-Q.

Cite this change

"Restructuring charges/other in the year-ago period was a credit of $124 million primarily due to a gain on the sale of a property during 2024."

Texas Instruments, Form 10-Q for FY2025, Part I, Item 2, accession 0000097476-25-000036, filed 29 July 2025.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747625000036/txn-20250630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

What the company says differently

Paragraphs that changed between the two filings, shown as a word diff.

30 material changes

Part I, Item 2 · MD&A

5 of 30 shown · Ordered by the model, quote-checked

01Figures updatedPart I, Item 2 › Performance summary

Summary · quote-checked

Trailing-twelve-month operating cash flow increased from $6.4 billion to $8.7 billion, while free cash flow increased from $1.8 billion to $6.5 billion.

The changed liquidity figures materially alter the amounts of cash generated and free cash flow, leading readers to a different conclusion about the company’s liquidity capacity.

Why the model ranked it here

The much stronger operating and free cash flow materially changes the reader’s view of the company’s cash-generation capacity.

Filing text · FY2025 10-Q · filed Jul 29, 2025

Our cash flow from operations of ~~[removed] $6.4~~ billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production. Free cash flow for the same period was ~~[removed] $1.8~~ billion.

Filing text · FY2026 10-Q · filed Jul 24, 2026

Our cash flow from operations of [added] $8.7 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production. Free cash flow for the same period was [added] $6.5 billion.

Cite this change

"Our cash flow from operations of $8.7 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production. Free cash flow for the same period was $6.5 billion."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

02ChangedPart I, Item 2 › Liquidity and capital resources

Summary · quote-checked

Capital expenditure disclosure becomes specific for 2026, and the CHIPS Act funding disclosure adds a 35% ITC and $630 million received.

The company changes its capital spending outlook from evaluation to a stated range and adds a received-funding amount, changing the disclosure about capital commitments and available support.

Why the model ranked it here

The company now states a capital-spending range and reports received government funding, making its investment commitments and available support more concrete.

Filing text · FY2025 10-Q · filed Jul 29, 2025

~~[removed] We are now mostly through a six-year elevated capital expenditures cycle, and consistent~~ with our capital management strategy, we ~~[removed] are currently evaluating our capital expenditure levels to determine if they will remain at elevated levels in 2026 and beyond,~~ dependent on revenue and growth expectations. ~~[removed] For qualifying manufacturing investments, we~~ expect to ~~[removed] benefit~~ from the ~~[removed] 25% ITC established by the CHIPS Act,~~ as well as direct funding of up to $1.6 ~~[removed] billion~~ for our three large-scale 300mm wafer fabs ~~[removed] currently under construction~~ in Sherman, Texas, and Lehi, Utah.~~[removed] The U.S. tax law changes within the OBBBA included an increase to the CHIPS Act ITC from 25% to 35% for qualifying manufacturing investments placed in service after December 31, 2025.~~

Filing text · FY2026 10-Q · filed Jul 24, 2026

[added] Consistent with our capital management strategy, we [added] expect between $2 billion to $3 billion of capital expenditures in 2026. Beyond 2026, capital expenditures will be dependent on revenue and growth expectations. [added] We expect to [added] continue benefiting from the [added] CHIPS Act. This includes the 35% ITC on qualifying manufacturing investments as well as direct funding of up to $1.6 [added] billion, of which we have received $630 million, for our three large-scale 300mm wafer fabs [added] located in Sherman, Texas, and Lehi, Utah.

Cite this change

"Consistent with our capital management strategy, we expect between $2 billion to $3 billion of capital expenditures in 2026. Beyond 2026, capital expenditures will be dependent on revenue and growth expectations. We expect to continue benefiting from the CHIPS Act. This includes the 35% ITC on qualifying manufacturing investments as well as direct funding of up to $1.6 billion, of which we have received $630 million, for our three large-scale 300mm wafer fabs located in Sherman, Texas, and Lehi, Utah."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

03ChangedPart I, Item 2 › Financial condition

Summary · quote-checked

Total cash changed from $5.36 billion with a decrease from 2024 to $7.00 billion with an increase from 2025.

The cash balance and direction of change both shifted, changing the filing’s stated liquidity position rather than merely rolling forward the reporting period.

Why the model ranked it here

The reversal from declining to growing total cash materially changes the stated liquidity position.

Filing text · FY2025 10-Q · filed Jul 29, 2025

At the end of the second quarter of ~~[removed] 2025,~~ total cash (cash and cash equivalents plus short-term investments) was ~~[removed] $5.36 billion, a decrease of $2.22~~ billion from the end of ~~[removed] 2024.~~

Filing text · FY2026 10-Q · filed Jul 24, 2026

At the end of the second quarter of [added] 2026, total cash (cash and cash equivalents plus short-term investments) was [added] $7.00 billion, an increase of $2.12 billion from the end of [added] 2025.

Cite this change

"At the end of the second quarter of 2026, total cash (cash and cash equivalents plus short-term investments) was $7.00 billion, an increase of $2.12 billion from the end of 2025."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

04Figures updatedPart I, Item 2 › Second quarter 2026 segment results

Summary · quote-checked

The segment table changed from revenue and operating profit growth to declines, with updated quarterly figures and percentages.

The figures do more than roll forward periods: both revenue and operating profit changed from positive growth to negative change, altering the stated performance direction.

Why the model ranked it here

The segment table changes from growth to decline in revenue and operating profit, altering the reader’s assessment of segment performance.

Filing text · FY2025 10-Q · filed Jul 29, 2025

|Q2 ~~[removed] 2025~~ | Q2 ~~[removed] 2024~~ | ChangeRevenue | $ | ~~[removed] 317~~ | $ | ~~[removed] 279 | 14~~ | %Operating profit ~~[removed] | 153 | 121 | 26~~ | %Operating profit % of revenue | ~~[removed] 48.3~~ | % | ~~[removed] 43.4~~ | %

Filing text · FY2026 10-Q · filed Jul 24, 2026

|Q2 2026 | Q2 2025 | ChangeRevenue | $ | 310 | $ | 317 | (2) | %Operating profit * | 150 | 153 | (2) | %Operating profit % of revenue | 48.4 | % | 48.3 | %

Cite this change

"Revenue | $ | 310 | $ | 317 | (2) | %"

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

05ChangedPart I, Item 2 › Second quarter 2026 segment results

Summary · quote-checked

Other revenue and operating profit changed from increases to decreases, with different dollar amounts reported.

The MD&A direction changes from increased to decreased for both metrics, making the results narrative substantively different under the rubric.

Why the model ranked it here

Other revenue and operating profit reverse from increases to decreases, materially changing the reported results narrative.

Filing text · FY2025 10-Q · filed Jul 29, 2025

Other revenue ~~[removed] increased $38~~ million, and operating profit ~~[removed] increased $32~~ million.

Filing text · FY2026 10-Q · filed Jul 24, 2026

Other revenue [added] decreased $7 million, and operating profit [added] decreased $3 million.

Cite this change

"Other revenue decreased $7 million, and operating profit decreased $3 million."

Texas Instruments, Form 10-Q for FY2026, Part I, Item 2, accession 0000097476-26-000152, filed 24 July 2026.

Filing: https://www.sec.gov/Archives/edgar/data/97476/000009747626000152/txn-20260630.htm

Comparison: https://yearover.com/reports/txn/0000097476-26-000152?ref=quote

Show all 30 in Part I, Item 2 (25 more, in filing order)

What the company reported as changed this quarter

We have not parsed the annual report this quarter's risk factors refers to, so we cannot tell whether it restates the section or reports changes to it. Nothing is compared until we can.

Part II, Item 1A · Risk Factors

Get this when TXN files next

At most one email a day, and only when a company we cover files. Over the last twelve months that averaged about 5 days a month, unevenly: 12 in the busiest month and 1 in the quietest. You confirm by email first; nothing is sent until you do.